Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial calcium uptake protein 1 (MICU1) is a single-pass membrane-associated protein located in the mitochondrial intermembrane space, where it serves as a calcium sensor and regulatory subunit for the mitochondrial calcium uniporter (MCU) complex[1][2][3][4][5]. MICU1 contains two EF-hand calcium-binding domains and regulates the MCU channel by setting a threshold for calcium uptake: at low cytosolic calcium, it inhibits MCU, and upon calcium binding (as cytosolic calcium rises), it undergoes conformational changes that relieve inhibition and permit mitochondrial calcium influx[2][3][4][5]. MICU1 also plays a distinct role in maintaining mitochondrial cristae structure and contact site organization (through interactions with the MICOS complex), independently of its calcium transport regulatory activities[7][8][9]. Germline mutations in MICU1 are associated with neuromuscular and metabolic disorders. Currently, MICU1 is considered a key regulatory protein in mitochondrial physiology and cell death, but is not a primary direct drug target[1][5][7][9].
Not applicable; MICU1 is a regulatory protein, not currently a direct drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial calcium uptake protein 1 (MICU1).